Physical Effect Menthol Extract Hydrogel Lumbago Pain Relief Gel Patch

Name: Physical Effect Menthol Extract Hydrogel Lumbago Pain Relief Gel Patch
Brand: Anhui Xuanwuyan Pharmaceutical Co., Ltd.
SKU: 2034301105

Anhui, ChinaAnhui Xuanwuyan Pharmaceutical Co., Ltd.

US$1.55

288-1,151 Box

US$1.35

1,152-2,159 Box

US$1.05

2,160+ Box

Sample price:US$6.00/box.Request sample

Product profile

Customization

Available

Cold Hot Dressing Application

Sciatica, Cervical Spondylitis, Rheumatism, Arthritis, Sprain, Muscle Strain

Usage Mode

For External Use

Model NO.

XWY-2021

Nature

Yes

Customized

Type

Body Pain Relief

Group

Adults, Middle-Aged and Old

Certification

CE, FDA, MSDS, GMP, Body Pain Relief

Size

10*14cm/Patch

Material

Hydrogel

Free Sample

Offered

OEM/ODM

Offered

Transport Package

Boxes, Carton

Specification

13.5cm x 1.5cm x 18cm/box

Trademark

XuanWuYan

Origin

Anhui, China

HS Code

3005109000

Production Capacity

50000pieces/Month

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceManagement CertificationProduct Certification

Anhui Xuanwuyan Pharmaceutical Co., Ltd.

Anhui, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs CertifiedExport Year: 10 YearsNearest Port: Shanghai, Yiwu, GuangzhouAverage Response Time: ≤1.97h

AI-Powered supplier vetting

SummaryAnhui Xuanwuyan Pharmaceutical Co., Ltd. is described as a technology-oriented company integrating research, production, sales, and operations. Its stated scope includes Class I and Class II medical devices, daily necessities, health products, and related technical services. Evidence shows OEM and ODM availability, customization from samples and designs, recent new-product development, CE and other product certifications, and documented procedures for service management and customer complaints. The supplier has export experience of 10 years, with exports accounting for 31%–40% of sales, and offers inventory capability and multiple payment and quotation terms. Limitations include no available SDK, only one R&D engineer, no Fortune 500 customer cooperation, no overseas warehouse or showroom, and no valid manufacturing-capacity contract with related subcontractors. Financial information is represented only by years, without performance figures sufficient for a substantive financial assessment.

Supplier typeThe supplier is identified as Anhui Xuanwuyan Pharmaceutical Co., Ltd., a company integrating research, production, sales, and operations. Its stated business scope covers production and sales of Class I and Class II medical devices, daily necessities, and health products, plus related technical research and consulting.

CertificationsThe supplier reports CE and other product-compliance certifications, as well as other management-system and sustainable-development certifications. The slices do not identify the specific additional certifications or their validity details, but CE certification is explicitly stated.

After-Sales capabilityThe supplier has written and followed procedures for service assessment, corrective and preventive actions, and customer complaint handling. It also reports inventory capability and one-month average lead times in both peak and off-season, but lacks an overseas warehouse and overseas showroom.

R&D capabilityThe supplier states that it had new products during the past year and offers ODM services, indicating product-development activity. However, it has no available SDK and reports only one R&D engineer, which limits the evidence of broader technical-development capacity.

Production capacityThe supplier lists multiple production machines, has a finished-product inspection method with written instructions that are uniformly followed, maintains inventory capability, and reports one-month average lead times. Nevertheless, it has no valid manufacturing-capacity contract with related subcontractors, so the full reliability and scale of production capacity are not completely demonstrated.

Customization capabilityCustomization from samples and customization from designs are explicitly available, and ODM services are offered. These statements directly support the supplier's ability to provide customized product development and manufacturing.

Client casesThe supplier reports OEM service for well-known brands and a repeat-buyer preference rate of 50%–80%. However, it reports no cooperation with Fortune 500 companies and provides no named customers or verifiable case details, so the strength and scale of its customer references remain limited.